BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 22343228)

  • 41. Personalizing ovarian cancer screening.
    Goozner M
    J Natl Cancer Inst; 2010 Aug; 102(15):1112-3. PubMed ID: 20668268
    [No Abstract]   [Full Text] [Related]  

  • 42. Ovarian cancer screening: new trial tries new twists.
    McNeil C
    J Natl Cancer Inst; 1995 Sep; 87(17):1283-5. PubMed ID: 7658479
    [No Abstract]   [Full Text] [Related]  

  • 43. Screening for ovarian cancer: is it worth the risk?
    Bell R
    Nurs Times; 1999 Jan 20-26; 95(3):52-3. PubMed ID: 10076394
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Screening for ovarian cancer.
    Quinn MA
    Aust Fam Physician; 2001 Jun; 30(6):530-4. PubMed ID: 11458578
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Mass-screening for ovarian cancer by means of transvaginal ultrasonography--study on size of ovary to select subjects requiring second screening].
    Sato S; Hasuo Y; Ohta S; Maruyama H; Kagiya A; Saito Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Sep; 44(9):1173-9. PubMed ID: 1453046
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CA-125: a biomarker put to the test.
    Schmidt C
    J Natl Cancer Inst; 2011 Sep; 103(17):1290-1. PubMed ID: 21852262
    [No Abstract]   [Full Text] [Related]  

  • 47. Ovarian cancer screening.
    Kurjak A; Predanic M
    Curr Opin Obstet Gynecol; 1994 Feb; 6(1):67-74. PubMed ID: 8180353
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Screening for ovarian cancer: U.S. Preventive Services Task Force reaffirmation recommendation statement.
    Moyer VA;
    Ann Intern Med; 2012 Dec; 157(12):900-4. PubMed ID: 22964825
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Psychological and behavioral impact of receipt of a "normal" ovarian cancer screening test.
    Gaugler JE; Pavlik E; Salsman JM; Andrykowski MA
    Prev Med; 2006 Jun; 42(6):463-70. PubMed ID: 16563482
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A comparison between an ultrasound based prediction model (LR2) and the risk of ovarian malignancy algorithm (ROMA) to assess the risk of malignancy in women with an adnexal mass.
    Kaijser J; Van Gorp T; Van Hoorde K; Van Holsbeke C; Sayasneh A; Vergote I; Bourne T; Timmerman D; Van Calster B
    Gynecol Oncol; 2013 May; 129(2):377-83. PubMed ID: 23360924
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ovarian cancer screening with annual transvaginal sonography: findings of 25,000 women screened.
    van Nagell JR; DePriest PD; Ueland FR; DeSimone CP; Cooper AL; McDonald JM; Pavlik EJ; Kryscio RJ
    Cancer; 2007 May; 109(9):1887-96. PubMed ID: 17373668
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Screening for early familial ovarian cancer with transvaginal ultrasonography and colour blood flow imaging.
    Bourne TH; Campbell S; Reynolds KM; Whitehead MI; Hampson J; Royston P; Crayford TJ; Collins WP
    BMJ; 1993 Apr; 306(6884):1025-9. PubMed ID: 8490496
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women.
    Skates SJ; Menon U; MacDonald N; Rosenthal AN; Oram DH; Knapp RC; Jacobs IJ
    J Clin Oncol; 2003 May; 21(10 Suppl):206s-210s. PubMed ID: 12743136
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ovarian cancer screening. American College of Radiology. ACR Appropriateness Criteria.
    Böhm-Vélez M; Mendelson E; Bree R; Finberg H; Fishman EK; Hricak H; Laing F; Sartoris D; Thurmond A; Goldstein S
    Radiology; 2000 Jun; 215 Suppl():861-71. PubMed ID: 11037511
    [No Abstract]   [Full Text] [Related]  

  • 55. [Ovarian cancer screening in the general population].
    Mathevet P; Delaloye JF
    Rev Med Suisse; 2013 Oct; 9(403):1943-4, 1946-9. PubMed ID: 24245016
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ovarian cancer screening.
    van Nagell JR; DePriest PD; Gallion HH; Pavlik EJ
    Cancer; 1993 Feb; 71(4 Suppl):1523-8. PubMed ID: 8431889
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ovarian cancer: screening, treatment, and followup.
    NIH Consens Statement; 1994 Apr 5-7; 12(3):1-30. PubMed ID: 7881476
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Current status of screening for ovarian cancer.
    Westhoff C
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S34-7. PubMed ID: 7835807
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Mass-screening for ovarian cancer by means of transvaginal ultrasonography].
    Sato S; Hasuo Y; Ohta S; Maruyama H; Kagiya A; Saito Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Jun; 44(6):683-8. PubMed ID: 1506730
    [TBL] [Abstract][Full Text] [Related]  

  • 60. NIH Consensus 1994: screening.
    Kramer BS; Gohagan J; Prorok PC
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S20-1. PubMed ID: 7835804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.